Quantopharmacological substantiation of potentiate analgetics properties of coffeine
Abstract
It was shown, that coffeine potentiate analgetic of the potassium salt of 2,4 dichlorbenzoic acid. It was conducted quantopharmacological researching of the coffeine molecule. Qvantopharmacological properties of the coffeine, which was established, are base of it molecular mechanism of potentiating analgetic action.
References
Apostolova ES, Mikhailyuk AI, Tsirelson VG Quantum chemical description of reactions. - M .: Izd. Morph Center, 1999. - 45 p.
Gloss S. Medical and biological statistics / trans. with English - М .: Практика, 1998. - 459 с.
Gribov LA, Mushtakava SP Quantum Chemistry: A Textbook. - M .: Gardariki, I999. - P. 390.
Karelov AE, Zaychik AM, Lebedinsky KM // Proceedings of the III Congress of Pharmacologists of Russia. - 2007. - V. 7, h. 1.- S. 1718.
Mashkovsky MD Medicines. - M .: OOO Novaya Volna, 2007. - T. 1. - S. 120—121.
Minkin VI, Simkin B.Ya., Minyaev RM Molecular structure theory. - Rostov-on-Don: Phoenix, 1997. - 560 p.
Heavenly T.Yu., Zagorodiy MI, Yagupova AS etc. // Ukr. nauk.-med. youth magazine. - 2007. - № 1-2. - P.19-23.
Heavenly T.Yu., Chekman IS // Наук. Bulletin of the National honey. Bogomolets University. - № 4. - 2006. - P. 79-86.
Solovyov ME, Solovyov MM Computer chemistry. - M .: Solon-press, 2005. - S. 175—185.
Stefanov OV (ed.). Preclinical study of drugs: Method. recommendations. - K., 2001.- 528 p.
Flenigen M., Komornicki E., McEver J. Semi-empirical methods for calculating the electronic structure / Ed. Sigala J. - M .: Mir, 1980. - T. 2. - S. 5—64.
Chekman IS, Gorchakova NO, Tumanov VA etc. Pharmacology. - К .: Вища шк „2001. - 598 с.
Zandvilet A.S., Huitema A.D., Jonge M.E. et al. //.. Basic and Clinical Pharmacology and Toxicology. - 2005. - Vol. 96. P. 71-79.
Diaz-Reval MI, Ventura-Martinez R., Hernandez-Delgadillo GP. et al. //.. Archive Medical Research - 2001. - Vol. 32, № 1. - P. 13-20.
Fredholm B.B. //.. Trends Pharmacology science. - 1980. - Vol. 1. ó P. 129ó132.
Ghelardini C., Galeotti N., Battolini A. // J. Archives of Pharmacology. - 1997. - Vol. 356, № 5. - P. 590-595.
Goldstein J. // J. Neurology. - 2008. № 71. ó P. 114ó121.
Laska EM // J. of the American Medical Association. - 1984. - Vol. 251, № 13. - P. 1711 - 1718.
Marchand S. // New England J. of Medicine. - 1995. - Vol. 333, № 5. ó P. 325ó326.
Schachtel BP, Fillingim J.M., Lane A.C. et al. //.. of Clinical Pharmacology. - 2007. - Vol. 47. P. 860-870.
Diamond S., Balm T.K., FreitagF.G. //.. Clinical Pharmacology and Therapeutics. - 2000. - Vol. 68. - P.312-319.
Vinegar R.E., Erickson J.F., Selph J.L. et al. //.. Proceedings of the Society for Experimental Biology and Medicine. - 1976. - Vol. 151. P. 556-560.
Yuan R., Madani S., Wei X. et al. //.. Drug Metabolism Disposition. - 2002. - Vol. 30. - P.1311-1319.
Zhang W.Y., Po A.L. //.. of Clinical Pharmacology and Therapeutics. - 1996. - Vol. 22, № 2. - P.79-97.
This work is licensed under a Creative Commons Attribution 4.0 International License.
